THE ECONOMIC IMPACT OF CYTOMEGALOVIRUS INFECTION AFTER LIVER TRANSPLANTATION-Reference-Cited by-同舟云学术

THE ECONOMIC IMPACT OF CYTOMEGALOVIRUS INFECTION AFTER LIVER TRANSPLANTATION

Published:2000-02 Issue:3 Volume:69 Page:357-361
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Kim W. Ray,Badley Andrew D.,Wiesner Russell H.,Porayko Michael K.,Seaberg Eric C.,Keating Michael R.,Evans Roger W.,Dickson E. Rolland,Krom Ruud A. F.,Paya Carlos V.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference20 articles.

1. Infections in solid-organ transplant recipients

2. ADVANCES IN THE DIAGNOSIS, TREATMENT, AND PREVENTION OF CYTOMEGALOVIRUS INFECTIONS AFTER LIVER TRANSPLANTATION

3. Interactions of Cytomegalovirus with the Human Immune System

4. Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysis

5. CYTOMEGALOVIRUS PROPHYLAXIS IN SOLID ORGAN TRANSPLANT RECIPIENTS

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients;Cochrane Database of Systematic Reviews;2024-05-03

2. Liver transplantation: cost analysis;Living Donor Organ Transplantation;2024

3. A Systematic Review and Meta-analysis of Optimized CMV Preemptive Therapy and Antiviral Prophylaxis for CMV Disease Prevention in CMV High-Risk (D+R-) Kidney Transplant Recipients;Transplantation Direct;2023-07-12

4. Individualized management of cytomegalovirus in solid organ transplant recipients;Expert Review of Precision Medicine and Drug Development;2021-08-17

5. Cost-effectiveness of Preemptive Therapy Versus Prophylaxis in a Randomized Clinical Trial for the Prevention of Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors;Clinical Infectious Diseases;2020-07-27